Pandx Ltd (Pandica)

We have developed a fully functional device with unique characteristics, which has undergone preliminary clinical evaluation and demonstrated its effectiveness. Russian and international (PCT) patent applications have been made covering the design, functionality and utility of IsyCath in diagnosing and treating diseases of gastrointestinal and hepato-biliary systems, as well as in other therapeutic areas. First Russian patent has been obtained (№ 2743144).
Social Link - Linkedin: http://www. linkedin.com/company /pandica
Employee Count: 4
Keywords: hospital & health care